{
  "docId": "019de076-c164-739c-925e-e97b24983f20",
  "docSlug": "45699c5d62cd10656fd74cee2718d284",
  "documentTitle": "AstraZeneca | Results Presentation Deck | 45 slides",
  "authorId": "astrazeneca",
  "authorName": "AstraZeneca",
  "documentKindSlug": "conference-presentation",
  "documentKindLabel": "Conference presentation",
  "sourceTypeSlug": "investor_relations",
  "sourceTypeLabel": "Investor relations",
  "presentationDate": "2024-02-01 00:00:00",
  "orientation": "landscape",
  "aspectRatio": 1.7777778,
  "pageNumber": 17,
  "pageCount": 45,
  "prevPage": 16,
  "nextPage": 18,
  "slideType": "customer_journey",
  "function": "size_opportunity",
  "density": "dense",
  "nDataPoints": 7,
  "notes": "The slide uses a patient journey/treatment line framework to map clinical trials and market status against patient population segments.",
  "elementsJson": null,
  "metadataConfidence": 0.95,
  "imagePath": null,
  "slideHref": "/slides/019de076-c164-739c-925e-e97b24983f20/17",
  "deckHref": "/decks/019de076-c164-739c-925e-e97b24983f20",
  "deckJsonHref": "/decks/019de076-c164-739c-925e-e97b24983f20.json",
  "deckAnchorHref": "/decks/019de076-c164-739c-925e-e97b24983f20#slide-17",
  "components": [
    {
      "bbox": {
        "h": 0.65,
        "w": 0.29,
        "x": 0.68,
        "y": 0.24
      },
      "kind": "callout",
      "text": "Truqap poised to redefine 2L HR+, potential SoC for altered tumours",
      "attrs": null,
      "subkind": "primary",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "bc89c207-ee3d-440a-89fe-4ea8ffa69cd7",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.65,
        "w": 0.64,
        "x": 0.03,
        "y": 0.24
      },
      "kind": "diagram",
      "text": "Treatment line landscape for HR+ metastatic breast cancer",
      "attrs": null,
      "subkind": "customer-journey",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "0a881744-8c76-453e-9b74-48d8dd955c4d",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.08,
        "w": 0.27,
        "x": 0.69,
        "y": 0.37
      },
      "kind": "metric",
      "text": "~28k patients diagnosed, treated with 2L HR+ disease in the US",
      "attrs": null,
      "subkind": "big-number",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "db5eb961-0057-4db8-a9e7-5d6b9fb5557a",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.08,
        "w": 0.29,
        "x": 0.68,
        "y": 0.84
      },
      "kind": "paragraph",
      "text": "Strong US launch momentum, filings underway in EU, JP",
      "attrs": null,
      "subkind": "paragraph",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "f58c1c03-0156-4bd8-b312-afec72d6d4bf",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.03,
        "w": 0.3,
        "x": 0.03,
        "y": 0.95
      },
      "kind": "source-note",
      "text": "1. AstraZeneca breast cancer epidemiology estimates. Appendix: Glossary.",
      "attrs": null,
      "subkind": null,
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "df0c21bd-7b4e-485e-b468-6dd835dadd14",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.05,
        "w": 0.94,
        "x": 0.03,
        "y": 0.06
      },
      "kind": "title",
      "text": "Oncology – Truqap launch reinforces breast cancer leadership",
      "attrs": null,
      "subkind": "headline",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "b86732f3-7e30-49b6-9ef4-5b59ecaae5fe",
      "frameworkName": null,
      "frameworkSlug": null
    }
  ],
  "metrics": [],
  "tools": [
    {
      "name": "Customer journey map",
      "slug": "customer-journey-map",
      "agent": null,
      "layer": "slide",
      "matchId": "fedd9c54-6161-4b90-b0ac-76eb5ff0ca4c",
      "evidence": "diagram/customer-journey: Treatment line landscape for HR+ metastatic breast cancer",
      "confidence": 0.8
    }
  ],
  "frameworks": [
    {
      "name": "customer-journey-map",
      "slug": null,
      "matchId": "1e3aeacf-0b99-4d3c-a005-8a20de040708",
      "evidence": "Maps patient treatment lines (1st to 4th line) against clinical trial positioning.",
      "confidence": 0.9
    }
  ],
  "arcBeats": [
    {
      "to": 26,
      "from": 10,
      "beatId": "43aa94ba-8d07-4798-99cd-6d40ae4b13e2",
      "arcName": "Monroe's Motivated Sequence",
      "arcSlug": "monroes-sequence",
      "beatName": "Satisfaction",
      "beatSlug": "monroes-sequence-satisfaction",
      "evidence": "The document provides an overview of AstraZeneca's financial results and pipeline success",
      "position": 2,
      "confidence": 0.8,
      "parentBeatName": "Turn",
      "parentBeatSlug": "turn"
    }
  ],
  "loops": [],
  "imagePathAlt": null,
  "thumbSrc": null,
  "thumbSrcAlt": null,
  "locked": true
}